Boehringer, Bayer to launch clinical trials Web sites

Boehringer, Bayer to launch clinical trials Web sites

 

Boehringer Ingelheim and Bayer joined the ranks of several other pharmas by announcing plans for their companies' clinical trial Web sites. Boehringer's will include all trials started today and after, and the company will post all ongoing trials by September 13, it reports. Results of completed trials will be posted one year after the drug is first approved and marketed in any country or within one year of the trial's completion. Boehringer says if a product is codeveloped or marketed with another company, the license holder will have the responsibility for providing trial information. Bayer's site will initially include information on 10 trials started after January 6, 2005, and will add trials started after today within three weeks of their start date, the company announced. By mid-September, Bayer says it will list all ongoing trials, concentrating mainly on phase III and IV trials, except in "exceptional cases," such as cancer research, which will include phase II information. Bayer also says by March 2006, all completed trials started after October 1, 2002, will be listed online.